[Form 4] Iridex Corp Insider Trading Activity

Rhea-AI Filing Summary

Iridex Corp (IRIX) reported insider purchases by Chief Financial Officer Romeo R. Dizon on 08/19/2025. The reporting person acquired a total of 1,500 shares through three purchase transactions: 1,000 shares at $1.18, 500 shares at $1.16, and an aggregate line showing 1,500 shares at $1.1593, bringing his direct holdings to 43,745 shares after the trades. The Form 4 was signed by an attorney-in-fact on 08/20/2025.

Positive

• CFO purchased shares: Romeo R. Dizon acquired a total of 1,500 shares on 08/19/2025, increasing his direct stake to 43,745 shares.
• Transparent reporting: Transactions were disclosed on a Form 4 and signed by an attorney-in-fact, meeting Section 16 reporting requirements.

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO made small open-market purchases totaling 1,500 shares at low single-dollar prices; impact appears minimal.

The transactions show direct purchases by the CFO on 08/19/2025 totaling 1,500 shares at prices around $1.16–$1.18, increasing his stake to 43,745 shares. For a public-company equity perspective, these are routine Section 16 purchases and, given the share counts and low per-share prices, are unlikely to materially change ownership or control. Monitor for any pattern of continued insider buying.

Corporate Governance Expert

TL;DR: Form 4 discloses routine insider purchases by an officer; filings and signature conform to Section 16 requirements.

The filing is straightforward: purchases executed on 08/19/2025 reported on Form 4 and signed by an attorney-in-fact. The reporting person is identified as the CFO and the transactions are reported as direct ownership. There are no indications of plan-based trades or dispositions, and no explanatory footnotes. Governance implications are limited absent additional context.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		P		1,000	A	$1.18	41,745	D
Common Stock	08/19/2025		P		500	A	$1.16	42,245	D
Common Stock	08/19/2025		P		1,500	A	$1.1593	43,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did IRIX report on this Form 4?

The CFO, Romeo R. Dizon, reported three open-market purchases on 08/19/2025 totaling 1,500 shares at prices around $1.16–$1.18.

How many shares does the reporting person own after the reported transactions?

After the transactions the reporting person beneficially owned 43,745 shares.

Were these purchases reported as direct or indirect ownership on the Form 4?

The Form 4 shows the ownership form as Direct (D) for the reported purchases.

When were the transactions executed and when was the Form 4 signed?

Transactions were executed on 08/19/2025 and the Form 4 was signed by an attorney-in-fact on 08/20/2025.

Does the Form 4 indicate any derivative transactions or dispositions?

No; Table II for derivative securities is blank and the form reports only purchases of common stock, no dispositions.